Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 1 The information of the collected clinical samples

From: Establishment of CD34 + hematopoietic stem cell-derived xenograft model of hyperleukocytic acute myeloid leukemia

Information

Patient #1

Patient #2

Patient #3

Gender

Male

Male

Female

Age (year)

44

27

28

Clinical diagnosis

AML-M5

AML-M1

AML-M1

Detection of gene mutation (PCR and sequencing)

DNMT3A (+)

NRAS (+)

NPM1 (+)

FLT3-TKD (+)

WT1 (+)

NRAS (+)

WT1 (+)

SET-CAN (+)

Immunophenotype (Flow cytometry)

Abnormal cells ratio

58.50%

74.6%

71.8%

Immunopheno-type expression

CD36, HLA-DR, CD11b, CD15, CD38, CD33, CD64

CD34, CD33, CD11b, CD7, CD123, CD99, CD71

CD7, CD34, CD33, CD19, CD11b, CD79a, CD38

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us